| Development and validation of a risk score to predict QT interval prolongation in hospitalized patients JE Tisdale, HA Jaynes, JR Kingery, NA Mourad, TN Trujillo, ... Circulation: Cardiovascular Quality and Outcomes 6 (4), 479-487, 2013 | 424 | 2013 |
| 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures G Frendl, AC Sodickson, MK Chung, AL Waldo, BJ Gersh, JE Tisdale, ... The Journal of thoracic and cardiovascular surgery 148 (3), e153-e193, 2014 | 364 | 2014 |
| Torsades de pointes associated with intravenous haloperidol in critically ill patients ND Sharma, HS Rosman, ID Padhi, JE Tisdale American Journal of Cardiology 81 (2), 238-240, 1998 | 292 | 1998 |
| QT interval prolongation and the risk of torsades de pointes: essentials for clinicians KE Trinkley, R Lee Page, H Lien, K Yamanouye, JE Tisdale Current medical research and opinion 29 (12), 1719-1726, 2013 | 280 | 2013 |
| Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management JE Tisdale Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 149 (3), 139-152, 2016 | 269 | 2016 |
| Drug-induced diseases: prevention, detection, and management JE Tisdale ASHP, 2010 | 259 | 2010 |
| 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint … JA Joglar, MK Chung, AL Armbruster, EJ Benjamin, JY Chyou, EM Cronin, ... Circulation 149 (1), e1-e156, 2024 | 177 | 2024 |
| Drug-induced arrhythmias: a scientific statement from the American Heart Association JE Tisdale, MK Chung, KB Campbell, M Hammadah, JA Joglar, J Leclerc, ... Circulation 142 (15), e214-e233, 2020 | 175 | 2020 |
| Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay? S Borzak, JE Tisdale, NB Amin, AD Goldberg, D Frank, ID Padhi, ... Chest 113 (6), 1489-1491, 1998 | 154 | 1998 |
| Electrophysiologic and proarrhythmic effects of intravenous inotropic agents JE Tisdale, R Patel, CR Webb, S Borzak, BJ Zarowitz Progress in cardiovascular diseases 38 (2), 167-180, 1995 | 128 | 1995 |
| A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery JE Tisdale, ID Padhi, AD Goldberg, NA Silverman, CR Webb, ... American heart journal 135 (5), 739-747, 1998 | 124 | 1998 |
| The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary HC Fernando, MT Jaklitsch, GL Walsh, JE Tisdale, CD Bridges, ... The Annals of thoracic surgery 92 (3), 1144-1152, 2011 | 123 | 2011 |
| Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence RS Slavik, JE Tisdale, S Borzak Progress in cardiovascular diseases 44 (2), 121-152, 2001 | 108 | 2001 |
| A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection JE Tisdale, HA Wroblewski, DS Wall, KM Rieger, ZT Hammoud, JV Young, ... The Annals of thoracic surgery 88 (3), 886-895, 2009 | 107 | 2009 |
| Risk factors for hypertensive crisis: importance of out-patient blood pressure control JE Tisdale, MB Huang, S Borzak Family Practice 21 (4), 420-424, 2004 | 106 | 2004 |
| Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective … JE Tisdale, HA Wroblewski, BR Overholser, JR Kingery, TN Trujillo, ... Drug safety 35, 459-470, 2012 | 103 | 2012 |
| Amiodarone Prophylaxis for Atrial Fibrillation After Cardiac Surgery: Meta‐Analysis of Dose Response and Timing of Initiation MS Buckley, PE Nolan Jr, MK Slack, JE Tisdale, DE Hilleman, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (3 …, 2007 | 95 | 2007 |
| Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients JE Tisdale, HA Jaynes, JR Kingery, BR Overholser, NA Mourad, ... Circulation: Cardiovascular Quality and Outcomes 7 (3), 381-390, 2014 | 89 | 2014 |
| Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors K Amankwa, SC Krishnan, JE Tisdale Clinical Pharmacology & Therapeutics 75 (3), 242-247, 2004 | 87 | 2004 |
| Proarrhythmic effects of intravenous vasopressors JE Tisdale, RV Patel, CR Webb, S Borzak, BJ Zarowitz Annals of Pharmacotherapy 29 (3), 269-281, 1995 | 86 | 1995 |
